{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:58:19Z","timestamp":1781179099648,"version":"3.54.1"},"reference-count":18,"publisher":"Scientific Scholar","issue":"02","license":[{"start":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:00:00Z","timestamp":1691712000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1055\/s-0043-1761443","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T19:28:06Z","timestamp":1691782086000},"page":"157-162","source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Cytokine Storm in SARS-CoV-2 Infected Patients with Hematolymphoid Malignancy: A New Perspective"],"prefix":"10.25259","volume":"13","author":[{"given":"Sujeet","family":"Kamtalwar","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National Institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-2207","authenticated-orcid":false,"given":"Sumeet","family":"Mirgh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"More","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National Institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Medical Administration, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Patkar","sequence":"additional","affiliation":[{"name":"Department of Hematopathology Laboratory, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sweta","family":"Rajpal","sequence":"additional","affiliation":[{"name":"Department of Hematopathology Laboratory, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Chatterjee","sequence":"additional","affiliation":[{"name":"Department of Hematopathology Laboratory, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Radiodiagnosis, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anant","family":"Gokarn","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Advanced Centre for Treatment, Research & Education in Cancer (ACTREC), Navi Mumbai and Homi Bhabha National institute (HBNI), Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,8,11]]},"reference":[{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1186\/s13054-020-03240-7","article-title":"Incidence of ARDS and outcomes in hospitalized patients with COVID-19: a global literature survey","volume":"24","author":"S J Tzotzos","year":"2020","journal-title":"Crit Care"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s42399-020-00363-4","article-title":"Comorbidity and its impact on patients with COVID-19","volume":"2","author":"A Sanyaolu","year":"2020","journal-title":"SN Compr Clin Med"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/s41416-021-01452-4","article-title":"Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study","volume":"125","author":"S Assaad","year":"2021","journal-title":"Br J Cancer"},{"issue":"24","key":"ref5","doi-asserted-by":"crossref","first-page":"8777","DOI":"10.1002\/cam4.4379","article-title":"Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary cancer centre in India","volume":"10","author":"S P Mirgh","year":"2021","journal-title":"Cancer Med"},{"issue":"19","key":"ref6","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","article-title":"Remdesivir for 5 or 10 days in patients with severe Covid-19","volume":"383","author":"J D Goldman","year":"2020","journal-title":"N Engl J Med"},{"issue":"08","key":"ref7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"P Horby","year":"2021","journal-title":"N Engl J Med"},{"issue":"01","key":"ref8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/s12879-021-06045-3","article-title":"Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial","volume":"21","author":"K Ranjbar","year":"2021","journal-title":"BMC Infect Dis"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41467-021-21085-8","article-title":"Efficacy and tolerability of bevacizumab in patients with severe Covid-19","volume":"12","author":"J Pang","year":"2021","journal-title":"Nat Commun"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1017\/S0950268821000662","article-title":"SARS-CoV-2 re-infection: development of an epidemiological definition from India","volume":"149","author":"A Mukherjee","year":"2021","journal-title":"Epidemiol Infect"},{"issue":"03","key":"ref11","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1470-2045(20)30096-6","article-title":"Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China","volume":"21","author":"W Liang","year":"2020","journal-title":"Lancet Oncol"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jnci\/djaa168","article-title":"Clinical characteristics and outcomes of COVID-19-infected cancer patients: a systematic review and meta-analysis","volume":"113","author":"H Zhang","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"102525","DOI":"10.1016\/j.bcmd.2020.102525","article-title":"Effect of age, comorbidity and remission status on outcome of COVID-19 in patients with hematological malignancies","volume":"87","author":"P Borah","year":"2021","journal-title":"Blood Cells Mol Dis"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1111\/bjh.16935","article-title":"Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience","volume":"190","author":"V Shah","year":"2020","journal-title":"Br J Haematol"},{"issue":"07","key":"ref15","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.cell.2020.10.049","article-title":"Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer","volume":"183","author":"V A Avanzato","year":"2020","journal-title":"Cell"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.3389\/fonc.2020.01578","article-title":"Prolonged course of COVID-19-associated pneumonia in a B-cell depleted patient after rituximab","volume":"10","author":"I Kos","year":"2020","journal-title":"Front Oncol"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.clml.2020.08.017","article-title":"Persistent COVID-19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphoma","volume":"20","author":"H Yasuda","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"01","key":"ref18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiaa666","article-title":"Prolonged severe acute respiratory syndrome coronavirus 2 replication in an immunocompromised patient","volume":"223","author":"J H Baang","year":"2021","journal-title":"J Infect Dis"},{"issue":"07","key":"ref19","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1093\/infdis\/jiaa446","article-title":"Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy","volume":"222","author":"M Helleberg","year":"2020","journal-title":"J Infect Dis"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0043-1761443.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:53Z","timestamp":1781176373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/recurrent-cytokine-storm-in-sars-cov-2-infected-patients-with-hematolymphoid-malignancy-a-new-perspective\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,11]]},"references-count":18,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2024,6,24]]},"published-print":{"date-parts":[[2024,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0043-1761443","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,11]]}}}